Diveen® to reduce female stress urinary incontinence

No time and no shame for bladder weakness

Two elderly women who exercise in the forest

When you have children, routines and procedures become very different and often it can be a real challenge to combine family life with your job or career. This is especially true for women. As a young mother, you want to cuddle, play, bounce, laugh, constantly do new things and share plenty of “first times” in your children’s lives. All the while tending to all the other chores you had to do before you became a mother. So, you certainly have no time for bladder weakness and the constant search for a toilet.

Some women may simply want to be able to laugh without worry or continue doing sports without feeling frustrated or ashamed because of urine leakages. There is no reason why you should not regain this sense of freedom and be self-confident.

Today, more than 24 million women in the United States are estimated to suffer from SUI. Since this disorder becomes more prevalent with age, the number is projected to increase due to ongoing demographic changes.This type of incontinence is often caused by pregnancy, childbirth, menopause, sports or urological complications.2 For women affected, Diveen® could be a real solution. 

What is Diveen®?

Diveen and the Diveen applicator

Diveen® is an innovative intravaginal device that is non-surgical in nature and discreet with an efficiency that is clinically proven to significantly reduce the risk of urine leakage.3

An innovative, patented concept is behind Diveen®; and it is specifically designed for women suffering from urinary incontinence, both stress and mixed.3

What are the advantages of Diveen®?

Diveen- available in two sizes and two box sizes
  • Discreet protection, as it is inserted in the vagina like a tampon.
  • A unique mechanism which significantly reduces of the risk of urine leakage.3
  • Made of biocompatible material.4
  • The product can remain in the vagina for up to 12 hours – which means peace of mind when you enjoy physical activity. Simply remove the device at night.

 

How does Diveen® work?

Diveen® was developed according to an innovative, patented concept to provide mechanical support to the anterior vaginal wall in the area below the bladder neck of women who suffer from stress urinary incontinence or mixed urinary incontinence.

The reason is that the intra-abdominal pressure suddenly increases during exertion such as coughing, creating a pressure peak which transmits itself via the bladder to the flexible ring of Diveen®. This in turn causes the rigid part of the device to move upwards, immediately supporting the urethra and significantly reducing the incidence of urine leakage.3

How to use Diveen®

Diveen usage 01

Before using the product, please wash your hands and stand in a comfortable position.

Diveen usage 02

Remove the applicator from the applicator tube.

Diveen usage 03

Gently press on the product's ring.

Diveen usage 04

Insert the ring into the applicator tube.

Place the applicator into the applicator tube. Diveen® can now be inserted. 

 

Insert the applicator tube into the vagina and gently push the applicator (like a tampon applicator).

Diveen usage 07

Remove the applicator.

Gently pull the attached string.

Clinically proven efficacy

The efficacy of Diveen® in the management of stress urinary incontinence in women3 has been established in clinical trials:

  • Reduce the incidence of urinary leakages by 69 percent on average.3
  • 78 of 100 patients who used the product were satisfied.3
  • Improve users' emotional well-being.3

 

References

(1) Wu JM, Hundley AF, Fulton RG. Forecasting the prevalence of pelvic floor disorders in US women 2010–2050. Obst Gynecol. 2009;114(6):1278–83.nn   

(2) Haab. F. et al. Traitement de l'incontinence urinaire d'effort par colposuspension percutanée: une technique non satisfaisante. Progrès en urologie 2001, 11:336-339

(3) Cornu J.N et al. 75NC007 device for noninvasive stress urinary incontinence management in women: a randomized contol trial. International Urogynecology Journal 2012, 23 (12): 1727-34

(4) Biological Evaluation Summary Report 7.14.AS.001, 2021 – Data on file